The Institute for Research in Immunology and Cancer – Commercialization of Research (IRICoR) of the Université de Montréal announces that the company will attend the BIO International Convention 2014. This conference is being held from June 23-26, 2014 at the San Diego Convention Center in San Diego, California.
This conference attracts key pharmaceutical and biotechnology companies from around the Word. It gives to the participants an opportunity to learn about investment trends and meet with leading dealmakers, strategic partners in Life Sciences. Many participants from various Life Sciences sector will be attending this conference.
For more information about BIO International Convention 2014 click here : BIO International Convention
About the Institute for Research in Immunology and Cancer – Commercialization of Research
IRICoR is a not-for-profit organization whose mandate is to accelerate the discovery, development and commercialization of novel drugs that originate at Université de Montreal’s Institute for Research in Immunology and Cancer and related research units. IRICoR invests in highly innovative projects to rapidly transition them from academia to the market, while identifying the best development partners for these commercially promising projects. For more information: www.iricor.ca
Steven Klein Ph.D., MBA
Business Development, Vice-President
T +1 514 343.6647